Hledat klinickou studii
8 Výsledků
Studie přijímající pacienty
= 
; Probíhající studie = 
; Ukončená studie = 
; Financováno členem konsorcia IRDiRC = 
; Člen ERN = 
Národní klinické studie
IRSKO
County Dublin
ADDRESS: NOT PROVIDED - IE
TOPAZ - Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acid-IE
Institution: Information not provided - IE
ŠVÉDSKO
Region Stockholm
SOLNA
BOOSTB4: An Exploratory, Open Label, Multiple Dose, Multicentre Phase I/II Trial Evaluating Safety and Efficacy of Postnatal or Prenatal and Postnatal Intravenous Administration of Allogeneic Expanded Fetal Mesenchymal Stem Cells for the Treatment of Severe Osteogenesis Imperfecta Compared With a Combination of Historical and Untreated Prospective Controls - SE
Astrid Lindgrens Barnsjukhus
Astrid Lindgren Children's Hospital
SPOJENÉ KRÁLOVSTVÍ
Edinburgh
EDINBURGH
TOPAZ - Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acid
University of Edinburgh
Edinburgh Clinical Trials Unit
RAKOUSKO
WIEN
ADDRESS: NOT PROVIDED - AT
An Open-label, Ascending Multiple-dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Romosozumab in Children and Adolescents With Osteogenesis Imperfecta - AT
Institution: Information not provided - AT
SPOJENÉ KRÁLOVSTVÍ
Oxfordshire
OXFORD
A Phase 2b Study, Multicentre, Multinational, Placebo-controlled, Double-blind, Dose-finding Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804-GB
Nuffield Orthopaedic Centre
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
Nadnárodní klinické studie
ŠVÉDSKO
Region Stockholm
ADDRESS: NOT PROVIDED - SE
BOOSTB4: An exploratory, open label, multiple dose, multicentre phase I/II trial evaluating safety and efficacy of postnatal or prenatal and postnatal intravenous administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe Osteogenesis Imperfecta compared with a combination of historical and untreated prospective controls.
Institution: Information not provided - SE
ŠVÝCARSKO
Suisse Romande
ADDRESS: NOT PROVIDED - CH
A randomized, open label intra-patient dose escalation study with an untreated reference group to evaluate safety and tolerability, pharmacokinetics, and pharmacodynamics of multiple infusions of BPS804 in adults with moderate osteogenesis imperfecta
Institution: Information not provided - CH
ŠVÝCARSKO
Suisse Romande
ADDRESS: NOT PROVIDED - CH